Post by argenx
120,895 followers
This year at #EULAR2026, we’re presenting new, important data across autoimmune rheumatic diseases, including Phase 2 findings in myositis and Sjogren’s disease. We’re eager to share our findings and contribute to the growing body of evidence supporting the potential of targeting FcRn to address significant unmet needs across autoimmune rheumatic diseases. Will we see you there? Explore the data we’ll share at EULAR here: https://bit.ly/4e6Vzi3 #TogetherWeDiscover
Video Content